Phenylephrine (Drops, Solvent, Suppositories) Instructions for Use
ATC Codes
C05AX (Other agents for the treatment of hemorrhoids and anal fissures for topical use)
C05AX03 (Agents for the treatment of hemorrhoids and anal fissures in combination)
Active Substance
Phenylephrine (Rec.INN registered by WHO)
Clinical-Pharmacological Group
Drug for topical treatment of hemorrhoids
Pharmacotherapeutic Group
Angioprotectors; agents for the treatment of hemorrhoids and anal fissures for topical use; other agents for the treatment of hemorrhoids and anal fissures for topical use
Pharmacological Action
Adrenomimetic. It has a direct stimulating effect predominantly on α-adrenergic receptors.
When used systemically, it causes constriction of arterioles, increases systemic vascular resistance and blood pressure. Cardiac output does not change or decreases, which is associated with reflex bradycardia (increased vagus nerve tone) in response to arterial hypertension. Phenylephrine increases blood pressure less sharply than norepinephrine and epinephrine but acts for a longer duration. This is apparently due to the fact that Phenylephrine is more stable and is not broken down by the influence of COMT. In average therapeutic doses, it has practically no effect on the CNS.
When used topically in ophthalmology, Phenylephrine has a pronounced vasoconstrictive effect, causes mydriasis, and may lower intraocular pressure in open-angle glaucoma.
When used in ENT practice, it has a vasoconstrictive effect due to stimulation of α1-receptors in the nasal mucosa, reduces swelling of the mucous membranes and tissue hyperemia, congestion in the nasal mucosa, and improves the patency of the nasal airways.
When used rectally, it has a local vasoconstrictive effect, which helps reduce exudation, tissue swelling, and itching in the anorectal area.
Pharmacokinetics
After oral administration, Phenylephrine is poorly absorbed from the gastrointestinal tract. It is metabolized with the participation of MAO in the intestinal wall and during the “first pass” through the liver. The bioavailability of phenylephrine is low.
After topical application, it undergoes systemic absorption.
Indications
Parenterally: to increase blood pressure in collapse and arterial hypotension associated with decreased vascular tone; as a vasoconstrictor during local anesthesia.
Topically in ophthalmology: iridocyclitis (to prevent the formation of posterior synechiae and reduce exudation from the iris); for diagnostic pupil dilation during ophthalmoscopy and other diagnostic procedures necessary to monitor the condition of the posterior segment of the eye; performing a provocative test in patients with a narrow anterior chamber angle profile and suspected angle-closure glaucoma; differential diagnosis of superficial and deep injection of the eyeball; “red eye” syndrome (to reduce hyperemia and irritation of the eye mucosa); accommodation spasm.
Topically in ENT practice: to reduce swelling of the nasopharyngeal mucosa in colds and allergic diseases.
Rectally: as a symptomatic agent for hemorrhoids, anal fissures, anal itching.
ICD codes
| ICD-10 code | Indication |
| H10 | Conjunctivitis |
| H20.0 | Acute and subacute iridocyclitis (anterior uveitis) |
| H20.1 | Chronic iridocyclitis |
| H52.5 | Disorders of accommodation |
| I95 | Hypotension |
| J00 | Acute nasopharyngitis (common cold) |
| J30.1 | Allergic rhinitis due to pollen |
| J30.3 | Other allergic rhinitis (perennial allergic rhinitis) |
| J31.0 | Chronic rhinitis (including ozaena, atrophic and hypertrophic rhinitis) |
| K60 | Fissure and fistula of anus and rectum |
| K64 | Hemorrhoids and perianal venous thrombosis |
| L29.3 | Unspecified anogenital pruritus |
| R55 | Syncope [syncopal attack] and collapse |
| Z01.0 | Examination of eyes and vision |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| ICD-11 code | Indication |
| 9A60.Z | Conjunctivitis, unspecified |
| 9A96.Y | Other specified anterior uveitis |
| 9A96.Z | Anterior uveitis, unspecified |
| 9D01.Z | Disorders of accommodation, unspecified |
| BA2Z | Hypotension, unspecified |
| CA00 | Acute nasopharyngitis |
| CA08.00 | Allergic rhinitis due to pollen |
| CA08.03 | Other allergic rhinitis |
| CA09.0 | Chronic rhinitis |
| DB50.Z | Fissure or fistula of anal region, unspecified |
| DB6Z | Hemorrhoids or perianal venous diseases, unspecified |
| DE2Z | Diseases of the digestive system, unspecified |
| EC90.5 | Anogenital pruritus |
| MG45.Z | Syncope and collapse, unspecified |
| QB9A | Preparatory procedures for subsequent treatment |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Suppositories
Used parenterally and topically in ophthalmology, ENT practice, rectally. The dose, method and scheme of application, duration of treatment are determined individually, depending on the indications, clinical situation, patient’s age and the used dosage form.
Drops
For instillation into the conjunctival sac.
The dose and scheme of application depend on the indications and the used dosage form.
Solvent
IV, IM, SC, topically on mucous membranes.
The dose depends on the indications.
Adverse Reactions
Systemic reactions increase or decrease in blood pressure, palpitation sensation, bradycardia, tachycardia, ventricular arrhythmias, angina pectoris, pulmonary edema, coronary artery occlusion, pulmonary embolism, cardiac arrest, insomnia, nervousness, tremor, anxiety, increased excitability, confusion, irritability, headache, dizziness, cerebral hemorrhage, paresthesia, weakness, exacerbation of hyperthyroidism, eye pain, mydriasis, dysuria, urinary retention, nausea, vomiting, increased salivation, dyspnea, allergic reactions, increased sweating, facial skin pallor.
Local reactions: with parenteral use – necrosis and scab formation upon entry into tissues or with SC injections; with use in ophthalmology – conjunctivitis, periorbital edema, burning sensation, blurred vision, irritation, discomfort sensation in the eye, increased lacrimation, increased intraocular pressure, reactive miosis the day after application; with use in ENT practice – sensation of burning, tingling or prickling in the nose, irritation of the nasal mucosa; with rectal use – contact dermatitis.
Contraindications
Hypersensitivity to phenylephrine; severe cardiovascular diseases, pheochromocytoma; arterial hypertension, glucose-6-phosphate dehydrogenase deficiency, porphyria, thyrotoxicosis, diabetes mellitus, angle-closure glaucoma, use concurrently with MAO inhibitors and within 14 days after discontinuation of their therapy; halothane or cyclopropane anesthesia; pregnancy, breastfeeding period; prematurity, childhood – depending on the dosage form; impaired tear production (for use in ophthalmology).
With caution coronary artery disease (especially after a recent myocardial infarction), angina pectoris, thrombosis of coronary, mesenteric and other visceral or peripheral vessels, pulmonary hypertension, ventricular arrhythmias, thromboembolism, atherosclerosis, obliterating thromboangiitis (Buerger’s disease), Raynaud’s disease, tendency of vessels to spasms during frostbite, diabetic endarteritis, thyroid dysfunction, metabolic acidosis, hypercapnia, hypoxia, impaired renal and/or liver function, use in patients with prostate diseases who have an increased risk of urinary retention, granulocytopenia, sickle cell anemia; elderly age; wearing contact lenses, after surgical interventions (for use in ophthalmology).
Use in Pregnancy and Lactation
Use during pregnancy and breastfeeding is not recommended.
Use in Hepatic Impairment
Should be used with caution in patients with impaired liver function.
Use in Renal Impairment
Should be used with caution in patients with impaired renal function.
Pediatric Use
Use in children is possible according to indications, in age-appropriate recommended doses and dosage forms. It is necessary to strictly follow the instructions in the phenylephrine drug leaflets regarding contraindications for the use of specific phenylephrine dosage forms in children of different ages.
Geriatric Use
Should be prescribed with caution to elderly patients to avoid worsening of concomitant diseases.
Special Precautions
With parenteral use during treatment, ECG indicators, blood pressure, minute volume of blood, circulation in the extremities and at the injection site should be monitored. Before starting or during therapy for shock states, correction of hypovolemia, hypoxia, acidosis and hypercapnia is mandatory. To prevent a repeated decrease in blood pressure after phenylephrine withdrawal, the dose should be reduced gradually, especially after a prolonged infusion. The infusion is resumed if systolic blood pressure decreases to 70-80 mm Hg.
With age, the number of adrenergic receptors sensitive to phenylephrine decreases. MAO inhibitors, increasing the pressor effect of sympathomimetics, can cause headaches, arrhythmias, vomiting, hypertensive crisis, therefore, if patients have taken MAO inhibitors in the previous 2-3 weeks, the doses of sympathomimetics should be reduced.
With topical use of phenylephrine, systemic adverse reactions may occur.
With topical use of phenylephrine in ophthalmology, repeated instillations over a short period of time may lead to less pronounced mydriasis than previously observed. This effect is more common in elderly patients. Due to significant contraction of the pupil dilator muscle, 30-45 minutes after instillation under the influence of phenylephrine, particles of pigment from the pigment layer of the iris may be detected in the fluid of the anterior chamber of the eye. The suspension in the chamber fluid must be differentiated from manifestations of anterior uveitis or from the entry of blood cells into the fluid of the anterior chamber.
Effect on the ability to drive vehicles and mechanisms
During treatment, patients should avoid driving vehicles and other activities requiring high concentration and speed of psychomotor reactions.
Drug Interactions
When using phenylephrine against the background of general anesthesia induced by halothane or cyclopropane, the development of ventricular fibrillation is possible.
With simultaneous use with MAO inhibitors, potentiation of phenylephrine effects is observed (including with topical application).
With simultaneous use, phenothiazines, alpha-adrenergic blockers (phentolamine), furosemide and other diuretics reduce the vasoconstrictor effect of phenylephrine.
With simultaneous use, guanethidine enhances the mydriatic effect of phenylephrine (with systemic absorption).
With simultaneous use, oxytocin, ergot alkaloids, tricyclic antidepressants, furazolidone, procarbazine, selegiline, sympathomimetics enhance the pressor effect, and the latter also increase arrhythmogenicity.
With simultaneous use, beta-adrenergic blockers reduce the cardiotonic activity; against the background of reserpine, arterial hypertension is possible.
With simultaneous use, Phenylephrine reduces the antianginal effect of nitrates, which, in turn, can reduce the pressor effect of phenylephrine and increase the risk of arterial hypotension.
With simultaneous use, thyroid hormones increase (mutually) the effectiveness of phenylephrine and the associated risk of coronary insufficiency (especially with coronary atherosclerosis).
With simultaneous use of phenylephrine with digoxin or other cardiac glycosides, the risk of cardiac rhythm disturbances and myocardial infarction increases.
The use of phenylephrine during childbirth to correct arterial hypotension against the background of the use of labor-stimulating agents (vasopressin, ergotamine, ergometrine, methylergometrine) may cause persistent increase in blood pressure in the postpartum period.
With topical use in ophthalmology, the mydriatic effect of phenylephrine is enhanced when used in combination with topical application of atropine. Due to the enhanced vasopressor action, tachycardia may develop.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical DisclaimerBrand (or Active Substance), Marketing Authorisation Holder, Dosage Form
Rectal suppositories 5 mg: 5, 10, or 15 pcs.
Marketing Authorization Holder
B-PHARM, LLC (Russia)
Manufactured By
Biopharmkombinat, LLC (Russia)
Dosage Form
 |
Phenylephrine | Rectal suppositories 5 mg: 5, 10, or 15 pcs. |
Dosage Form, Packaging, and Composition
Rectal suppositories from almost white to light yellow in color, opaque, torpedo-shaped; the presence of an air core or funnel-shaped depression is allowed.
| 1 supp. | |
| Phenylephrine hydrochloride | 5 mg |
Excipients: cocoa bean oil – 1770 mg, corn starch – 224.2 mg, methylparahydroxybenzoate – 0.4 mg, propylparahydroxybenzoate – 0.4 mg.
5 pcs. – contour cell packs (1) – cardboard packs.
5 pcs. – contour cell packs (2) – cardboard packs.
5 pcs. – contour cell packs (3) – cardboard packs.
Eye drops 2.5%: dropper bottle 5 ml, 10 ml
Marketing Authorization Holder
Kosmofarm, LLC (Russia)
Manufactured By
Slavic Pharmacy, LLC (Russia)
Dosage Form
 |
Phenylephrine | Eye drops 2.5%: dropper bottle 5 ml, 10 ml |
Dosage Form, Packaging, and Composition
Eye drops in the form of a clear solution from colorless to yellow or yellow-brown in color.
| 1000 ml | |
| Phenylephrine hydrochloride | 25 mg |
Excipients: macrogol 300, sodium hyaluronate, water for injections.
5 ml – polymer dropper bottle (1) – cardboard packs.
10 ml – polymer dropper bottle (1) – cardboard packs.
Eye drops 2.5%: dropper bottle 5 ml
Marketing Authorization Holder
Moscow Endocrine Plant FSUE (Russia)
Dosage Form
|
Phenylephrine | Eye drops 2.5%: dropper bottle 5 ml |
Dosage Form, Packaging, and Composition
Eye drops in the form of a clear liquid, from colorless to light yellow in color.
| 1 ml | |
| Phenylephrine hydrochloride | 25 mg |
Excipients: benzalkonium chloride 50% solution – 0.2 mg (equivalent to 0.1 mg benzalkonium chloride), disodium edetate – 1 mg, sodium metabisulfite – 3 mg, sodium hydroxide – 0.24 mg, sodium citrate dihydrate – 5 mg, citric acid monohydrate – 1 mg, water for injections – up to 1 ml.
5 ml – dropper bottles – cardboard packs.
Rectal suppositories 5 mg: 5, 6, 10, 12, 15, or 18 pcs.
Marketing Authorization Holder
Salvus, LLC (Russia)
Manufactured By
Biopharmkombinat, LLC (Russia)
Dosage Form
|
Phenylephrine | Rectal suppositories 5 mg: 5, 6, 10, 12, 15, or 18 pcs. |
Dosage Form, Packaging, and Composition
Rectal suppositories from almost white to light yellow in color, opaque, torpedo-shaped; the presence of an air core or funnel-shaped depression is allowed.
| 1 supp. | |
| Phenylephrine hydrochloride | 5 mg |
Excipients: cocoa bean oil – 1770 mg, corn starch – 224.2 mg, methylparahydroxybenzoate – 0.4 mg, propylparahydroxybenzoate – 0.4 mg.
5 pcs. – contour cell packs (1) – cardboard packs.
5 pcs. – contour cell packs (2) – cardboard packs.
5 pcs. – contour cell packs (3) – cardboard packs.
6 pcs. – contour cell packs (1) – cardboard packs.
6 pcs. – contour cell packs (2) – cardboard packs.
6 pcs. – contour cell packs (3) – cardboard packs.
Rectal suppositories 5 mg: from 1 to 100 pcs.
Marketing Authorization Holder
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Phenylephrine | Rectal suppositories 5 mg: from 1 to 100 pcs. |
Dosage Form, Packaging, and Composition
Rectal suppositories from almost white to light yellow in color, opaque, torpedo-shaped; a longitudinal section may have an air core or a funnel-shaped depression.
| 1 supp. | |
| Phenylephrine hydrochloride | 5 mg |
Excipients: cocoa butter – 1770 mg, corn starch – 224.2 mg, methylparaben – 0.4 mg, propylparaben – 0.4 mg.
From 1 to 10 pcs. – contour cell packs (from 1 to 10 pcs.) – cardboard packs.
Rectal suppositories 5 mg: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 15, 16, 18, 20, 21, 24, 25, 27, 28, 30, 32, 35, 36, 40, 42, 45, 48, 49, 50, 54, 56, 60, 63, 64, 70, 72, 80, 81, 90, or 100 pcs.
Marketing Authorization Holder
Pharmregister LLC (Russia)
Manufactured By
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Phenylephrine | Rectal suppositories 5 mg: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 15, 16, 18, 20, 21, 24, 25, 27, 28, 30, 32, 35, 36, 40, 42, 45, 48, 49, 50, 54, 56, 60, 63, 64, 70, 72, 80, 81, 90, or 100 pcs. |
Dosage Form, Packaging, and Composition
Rectal suppositories from almost white to light yellow in color, opaque, torpedo-shaped; a longitudinal section may have an air core or a funnel-shaped depression.
| 1 supp. | |
| Phenylephrine hydrochloride | 5 mg |
Excipients: cocoa butter – 1770 mg, corn starch – 224.2 mg, methylparaben – 0.4 mg, propylparaben – 0.4 mg.
1 pc. – contour cell packs (1) – cardboard packs.
1 pc. – contour cell packs (2) – cardboard packs.
1 pc. – contour cell packs (3) – cardboard packs.
1 pc. – contour cell packs (4) – cardboard packs.
1 pc. – contour cell packs (5) – cardboard packs.
1 pc. – contour cell packs (6) – cardboard packs.
1 pc. – contour cell packs (7) – cardboard packs.
1 pc. – contour cell packs (8) – cardboard packs.
1 pc. – contour cell packs (9) – cardboard packs.
1 pc. – contour cell packs (10) – cardboard packs.
2 pcs. – contour cell packs (1) – cardboard packs.
2 pcs. – contour cell packs (2) – cardboard packs.
2 pcs. – contour cell packs (3) – cardboard packs.
2 pcs. – contour cell packs (4) – cardboard packs.
2 pcs. – contour cell packs (5) – cardboard packs.
2 pcs. – contour cell packs (6) – cardboard packs.
2 pcs. – contour cell packs (7) – cardboard packs.
2 pcs. – contour cell packs (8) – cardboard packs.
2 pcs. – contour cell packs (9) – cardboard packs.
2 pcs. – contour cell packs (10) – cardboard packs.
3 pcs. – contour cell packs (1) – cardboard packs.
3 pcs. – contour cell packs (2) – cardboard packs.
3 pcs. – contour cell packs (3) – cardboard packs.
3 pcs. – contour cell packs (4) – cardboard packs.
3 pcs. – contour cell packs (5) – cardboard packs.
3 pcs. – contour cell packs (6) – cardboard packs.
3 pcs. – contour cell packs (7) – cardboard packs.
3 pcs. – contour cell packs (8) – cardboard packs.
3 pcs. – contour cell packs (9) – cardboard packs.
3 pcs. – contour cell packs (10) – cardboard packs.
4 pcs. – contour cell packs (1) – cardboard packs.
4 pcs. – contour cell packs (2) – cardboard packs.
4 pcs. – contour cell packs (3) – cardboard packs.
4 pcs. – contour cell packs (4) – cardboard packs.
4 pcs. – contour cell packs (5) – cardboard packs.
4 pcs. – contour cell packs (6) – cardboard packs.
4 pcs. – contour cell packs (7) – cardboard packs.
4 pcs. – contour cell packs (8) – cardboard packs.
4 pcs. – contour cell packs (9) – cardboard packs.
4 pcs. – contour cell packs (10) – cardboard packs.
5 pcs. – contour cell packs (1) – cardboard packs.
5 pcs. – contour cell packs (2) – cardboard packs.
5 pcs. – contour cell packs (3) – cardboard packs.
5 pcs. – contour cell packs (4) – cardboard packs.
5 pcs. – contour cell packs (5) – cardboard packs.
5 pcs. – contour cell packs (6) – cardboard packs.
5 pcs. – contour cell packs (7) – cardboard packs.
5 pcs. – contour cell packs (8) – cardboard packs.
5 pcs. – contour cell packs (9) – cardboard packs.
5 pcs. – contour cell packs (10) – cardboard packs.
6 pcs. – contour cell packs (1) – cardboard packs.
6 pcs. – contour cell packs (2) – cardboard packs.
6 pcs. – contour cell packs (3) – cardboard packs.
6 pcs. – contour cell packs (4) – cardboard packs.
6 pcs. – contour cell packs (5) – cardboard packs.
6 pcs. – contour cell packs (6) – cardboard packs.
6 pcs. – contour cell packs (7) – cardboard packs.
6 pcs. – contour cell packs (8) – cardboard packs.
6 pcs. – contour cell packs (9) – cardboard packs.
6 pcs. – contour cell packs (10) – cardboard packs.
7 pcs. – contour cell packs (1) – cardboard packs.
7 pcs. – contour cell packs (2) – cardboard packs.
7 pcs. – contour cell packs (3) – cardboard packs.
7 pcs. – contour cell packs (4) – cardboard packs.
7 pcs. – contour cell packs (5) – cardboard packs.
7 pcs. – contour cell packs (6) – cardboard packs.
7 pcs. – contour cell packs (7) – cardboard packs.
7 pcs. – contour cell packs (8) – cardboard packs.
7 pcs. – contour cell packs (9) – cardboard packs.
7 pcs. – contour cell packs (10) – cardboard packs.
8 pcs. – contour cell packs (1) – cardboard packs.
8 pcs. – contour cell packs (2) – cardboard packs.
8 pcs. – contour cell packs (3) – cardboard packs.
8 pcs. – contour cell packs (4) – cardboard packs.
8 pcs. – contour cell packs (5) – cardboard packs.
8 pcs. – contour cell packs (6) – cardboard packs.
8 pcs. – contour cell packs (7) – cardboard packs.
8 pcs. – contour cell packs (8) – cardboard packs.
8 pcs. – contour cell packs (9) – cardboard packs.
8 pcs. – contour cell packs (10) – cardboard packs.
9 pcs. – contour cell packs (1) – cardboard packs.
9 pcs. – contour cell packs (2) – cardboard packs.
9 pcs. – contour cell packs (3) – cardboard packs.
9 pcs. – contour cell packs (4) – cardboard packs.
9 pcs. – contour cell packs (5) – cardboard packs.
9 pcs. – contour cell packs (6) – cardboard packs.
9 pcs. – contour cell packs (7) – cardboard packs.
9 pcs. – contour cell packs (8) – cardboard packs.
9 pcs. – contour cell packs (9) – cardboard packs.
9 pcs. – contour cell packs (10) – cardboard packs.
10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
10 pcs. – contour cell packs (4) – cardboard packs.
10 pcs. – contour cell packs (5) – cardboard packs.
10 pcs. – contour cell packs (6) – cardboard packs.
10 pcs. – contour cell packs (7) – cardboard packs.
10 pcs. – contour cell packs (8) – cardboard packs.
10 pcs. – contour cell packs (9) – cardboard packs.
10 pcs. – contour cell packs (10) – cardboard packs.
Rectal suppositories 5 mg: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 15, 16, 18, 20, 21, 24, 25, 27, 28, 30, 32, 35, 36, 40, 42, 45, 48, 49, 50, 54, 56, 60, 63, 64, 70, 72, 80, 81, 90, or 100 pcs.
Marketing Authorization Holder
Formula-FR, LLC (Russia)
Manufactured By
Tula Pharmaceutical Factory, LLC (Russia)
Dosage Form
|
Phenylephrine | Rectal suppositories 5 mg: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, 15, 16, 18, 20, 21, 24, 25, 27, 28, 30, 32, 35, 36, 40, 42, 45, 48, 49, 50, 54, 56, 60, 63, 64, 70, 72, 80, 81, 90, or 100 pcs. |
Dosage Form, Packaging, and Composition
Rectal suppositories opaque, from almost white to light yellow in color, torpedo-shaped. A longitudinal section may have an air core or a funnel-shaped depression.
| 1 supp. | |
| Phenylephrine hydrochloride | 5 mg |
Excipients: cocoa butter – 1770 mg, corn starch – 224.2 mg, methylparaben – 0.4 mg.
1 pc. – contour cell pack (1) – cardboard packs.
1 pc. – contour cell pack (2) – cardboard packs.
1 pc. – contour cell pack (3) – cardboard packs.
1 pc. – contour cell pack (4) – cardboard packs.
1 pc. – contour cell pack (5) – cardboard packs.
1 pc. – contour cell pack (6) – cardboard packs.
1 pc. – contour cell pack (7) – cardboard packs.
1 pc. – contour cell pack (8) – cardboard packs.
1 pc. – contour cell pack (9) – cardboard packs.
1 pc. – contour cell pack (10) – cardboard packs.
2 pcs. – contour cell pack (1) – cardboard packs.
2 pcs. – contour cell pack (2) – cardboard packs.
2 pcs. – contour cell pack (3) – cardboard packs.
2 pcs. – contour cell pack (4) – cardboard packs.
2 pcs. – contour cell pack (5) – cardboard packs.
2 pcs. – contour cell pack (6) – cardboard packs.
2 pcs. – contour cell pack (7) – cardboard packs.
2 pcs. – contour cell pack (8) – cardboard packs.
2 pcs. – contour cell pack (9) – cardboard packs.
2 pcs. – contour cell pack (10) – cardboard packs.
3 pcs. – contour cell pack (1) – cardboard packs.
3 pcs. – contour cell pack (2) – cardboard packs.
3 pcs. – contour cell pack (3) – cardboard packs.
3 pcs. – contour cell pack (4) – cardboard packs.
3 pcs. – contour cell pack (5) – cardboard packs.
3 pcs. – contour cell pack (6) – cardboard packs.
3 pcs. – contour cell pack (7) – cardboard packs.
3 pcs. – contour cell pack (8) – cardboard packs.
3 pcs. – contour cell pack (9) – cardboard packs.
3 pcs. – contour cell pack (10) – cardboard packs.
4 pcs. – contour cell pack (1) – cardboard packs.
4 pcs. – contour cell pack (2) – cardboard packs.
4 pcs. – contour cell pack (3) – cardboard packs.
4 pcs. – contour cell pack (4) – cardboard packs.
4 pcs. – contour cell pack (5) – cardboard packs.
4 pcs. – contour cell pack (6) – cardboard packs.
4 pcs. – contour cell pack (7) – cardboard packs.
4 pcs. – contour cell pack (8) – cardboard packs.
4 pcs. – contour cell pack (9) – cardboard packs.
4 pcs. – contour cell pack (10) – cardboard packs.
5 pcs. – contour cell pack (1) – cardboard packs.
5 pcs. – contour cell pack (2) – cardboard packs.
5 pcs. – contour cell pack (3) – cardboard packs.
5 pcs. – contour cell pack (4) – cardboard packs.
5 pcs. – contour cell pack (5) – cardboard packs.
5 pcs. – contour cell pack (6) – cardboard packs.
5 pcs. – contour cell pack (7) – cardboard packs.
5 pcs. – contour cell pack (8) – cardboard packs.
5 pcs. – contour cell pack (9) – cardboard packs.
5 pcs. – contour cell pack (10) – cardboard packs.
6 pcs. – contour cell pack (1) – cardboard packs.
6 pcs. – contour cell pack (2) – cardboard packs.
6 pcs. – contour cell pack (3) – cardboard packs.
6 pcs. – contour cell pack (4) – cardboard packs.
6 pcs. – contour cell pack (5) – cardboard packs.
6 pcs. – contour cell pack (6) – cardboard packs.
6 pcs. – contour cell pack (7) – cardboard packs.
6 pcs. – contour cell pack (8) – cardboard packs.
6 pcs. – contour cell pack (9) – cardboard packs.
6 pcs. – contour cell pack (10) – cardboard packs.
7 pcs. – contour cell pack (1) – cardboard packs.
7 pcs. – contour cell pack (2) – cardboard packs.
7 pcs. – contour cell pack (3) – cardboard packs.
7 pcs. – contour cell pack (4) – cardboard packs.
7 pcs. – contour cell pack (5) – cardboard packs.
7 pcs. – contour cell pack (6) – cardboard packs.
7 pcs. – contour cell pack (7) – cardboard packs.
7 pcs. – contour cell pack (8) – cardboard packs.
7 pcs. – contour cell pack (9) – cardboard packs.
7 pcs. – contour cell pack (10) – cardboard packs.
8 pcs. – contour cell pack (1) – cardboard packs.
8 pcs. – contour cell pack (2) – cardboard packs.
8 pcs. – contour cell pack (3) – cardboard packs.
8 pcs. – contour cell pack (4) – cardboard packs.
8 pcs. – contour cell pack (5) – cardboard packs.
8 pcs. – contour cell pack (6) – cardboard packs.
8 pcs. – contour cell pack (7) – cardboard packs.
8 pcs. – contour cell pack (8) – cardboard packs.
8 pcs. – contour cell pack (9) – cardboard packs.
8 pcs. – contour cell pack (10) – cardboard packs.
9 pcs. – contour cell pack (1) – cardboard packs.
9 pcs. – contour cell pack (2) – cardboard packs.
9 pcs. – contour cell pack (3) – cardboard packs.
9 pcs. – contour cell pack (4) – cardboard packs.
9 pcs. – contour cell pack (5) – cardboard packs.
9 pcs. – contour cell pack (6) – cardboard packs.
9 pcs. – contour cell pack (7) – cardboard packs.
9 pcs. – contour cell pack (8) – cardboard packs.
9 pcs. – contour cell pack (9) – cardboard packs.
9 pcs. – contour cell pack (10) – cardboard packs.
10 pcs. – contour cell pack (1) – cardboard packs.
10 pcs. – contour cell pack (2) – cardboard packs.
10 pcs. – contour cell pack (3) – cardboard packs.
10 pcs. – contour cell pack (4) – cardboard packs.
10 pcs. – contour cell pack (5) – cardboard packs.
10 pcs. – contour cell pack (6) – cardboard packs.
10 pcs. – contour cell pack (7) – cardboard packs.
10 pcs. – contour cell pack (8) – cardboard packs.
10 pcs. – contour cell pack (9) – cardboard packs.
10 pcs. – contour cell pack (10) – cardboard packs.
Solution for injection 10 mg/1 ml: 1 ml amp. 5, 10, 20 or 25 pcs.
Marketing Authorization Holder
Ellara, LLC (Russia)
Dosage Form
|
Phenylephrine | Solution for injection 10 mg/1 ml: 1 ml amp. 5, 10, 20 or 25 pcs. |
Dosage Form, Packaging, and Composition
Solution for injection clear, colorless.
| 1 ml | |
| Phenylephrine hydrochloride | 10 mg |
Excipients: glycerol (glycerin) – 60 mg, water for injection – up to 1 ml.
1 ml – ampoules (5) – contour cell packs (1) – cardboard packs.
1 ml – ampoules (5) – contour cell packs (2) – cardboard packs.
1 ml – ampoules (5) – contour cell packs (4) – cardboard packs.
1 ml – ampoules (5) – contour cell packs (5) – cardboard packs.
1 ml – ampoules (5) – cardboard packs with corrugated insert.
1 ml – ampoules (10) – cardboard packs with corrugated insert.
![Phenylephrine [Drops, Solvent, Suppositories] 1](https://www.medixlife.com/wp-content/uploads/Medixlife_favi_512.png "Phenylephrine [Drops, Solvent, Suppositories] 2")